Albertsons Q1 Misses, Slashes Outlook, and Launches Major Restructuring Amid Opioid Trial
ACI is trading near its 52-week low of $10.86 (4.0% above the low).
Summary
Albertsons Q1 earnings missed expectations, prompting a full-year profit outlook cut and a major operational restructuring. The CFO is retiring, and opioid litigation risks are escalating with a Washington trial ongoing.
Key Events · Earnings and Guidance · ACI
-
Q1 Earnings Miss
Net income fell to $84.7M ($0.17/share) from $236.4M a year ago. Adjusted EBITDA declined to $1,013M from $1,111M. Identical sales dropped 0.8%.
-
Full-Year Outlook Cut
Management slashed its profit forecast, citing pressured unit volumes and value-conscious consumers. Identical sales are now expected to decline.
-
Major Restructuring (ACI Edge)
Company is consolidating 11 divisions into 4 regions and centralizing center-store merchandising to improve efficiency and accountability.
-
CFO Retirement
President and CFO Sharon McCollam will retire later this year; a successor search is underway.
Analysis · ACI · Trade & Services
A sharp drop in profitability underscores the quarter, with net income falling to $85M from $236M a year ago as margin compression and higher costs take hold. Identical sales declined 0.8% despite a 13% surge in digital growth. In response, the company announced a sweeping restructuring—ACI Edge—that consolidates divisions and centralizes merchandising, while also disclosing the retirement of its President and CFO. The opioid overhang remains critical: a Washington state trial is underway, and a Dallas County trial is set for September. On the balance sheet, $700M is drawn on the ABL and a $773.8M opioid settlement liability weighs, yet aggressive buybacks continue. The stock trades near its 52-week low, reflecting deep investor concern.
At the time of this filing, ACI was trading at $11.30 on NYSE in the Trade & Services sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $10.86 to $20.47. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.